Verbena Officinalis Market
The market for Verbena Officinalis was estimated at $564 million in 2024; it is anticipated to increase to $875 million by 2030, with projections indicating growth to around $1.26 billion by 2035.
Global Verbena Officinalis Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The Verbena Officinalis industry revenue is expected to be around $606.3 million in 2025 and expected to showcase growth with 7.6% CAGR between 2025 and 2034. The industry’s expansion reflects the growing global preference for plant-based ingredients across health, wellness, and personal care markets. Increasing consumer awareness regarding natural remedies and herbal therapeutics has strengthened the commercial relevance of verbena officinalis within botanical extracts and herbal supplement segments. Demand is particularly supported by the rise of preventive healthcare practices and the shift toward functional herbal formulations used in dietary supplements, herbal teas, and natural skincare products. Manufacturers are actively investing in standardized botanical extraction processes and quality certification to meet regulatory and consumer expectations. In addition, the expansion of herbal medicine distribution channels through e-commerce and specialty wellness retailers is improving accessibility. These dynamics collectively reinforce the importance of verbena officinalis as a valuable botanical ingredient in the evolving global herbal products industry.
Verbena officinalis, commonly known as common vervain, is a perennial medicinal herb widely recognized for its therapeutic and aromatic properties. The plant contains bioactive compounds such as flavonoids, iridoid glycosides, and essential oils that contribute to its anti-inflammatory, antioxidant, and mild sedative effects. It is commonly used in herbal medicine formulations for digestive health, stress relief, respiratory support, and mild sleep disorders. In addition to pharmaceutical and nutraceutical applications, verbena officinalis is also utilized in herbal teas, natural cosmetics, and aromatherapy products. Recent market trends highlight growing interest in plant-derived wellness ingredients, particularly in Europe and Asia where traditional herbal medicine practices remain influential. Increasing research into botanical extracts and the rising popularity of clean-label herbal supplements are further supporting demand for verbena officinalis across multiple health and wellness product categories.
Market Key Insights
The Verbena Officinalis market is projected to grow from $563.5 million in 2024 to $1.17 billion in 2034. This represents a CAGR of 7.6%, reflecting rising demand across Herbal Medicine, Cosmetic Industry, and Aromatherapy.
Mountain Rose Herbs, Starwest Botanicals, Frontier Co-op are among the leading players in this market, shaping its competitive landscape.
U.S. and Germany are the top markets within the Verbena Officinalis market and are expected to observe the growth CAGR of 4.9% to 7.3% between 2024 and 2030.
Emerging markets including Brazil, South Korea and UAE are expected to observe highest growth with CAGR ranging between 8.7% to 10.5%.
Transition like Transition from Traditional Herbal Remedies to Standardized Botanical Extracts is expected to add $83 million to the Verbena Officinalis market growth by 2030.
The Verbena Officinalis market is set to add $609 million between 2024 and 2034, with manufacturer targeting Cosmetic & Food & Beverage Application projected to gain a larger market share.
With
increasing consumer interest in natural remedies and advancements in herbal extraction techniques, and
Rising Popularity of Aromatherapy, Verbena Officinalis market to expand 108% between 2024 and 2034.